Accendra Health收到纽约证券交易所通知

2026-10-10 04:19

Accendra Health (ACH) said on Friday it received a notice from the NYSE after its average closing share price fell below $1 for 30 consecutive trading days.
The company plans to notify the NYSE of its intent to cure the deficiency within 10 business days and has six months to regain compliance.
Accendra Health is considering options, including a reverse stock split subject to shareholder approval at its next annual meeting, expected in May 2027.
The company shares will continue trading on the NYSE during the six-month compliance period, subject to meeting other listing standards.
Share -3.43%

More on Accendra Health